Nutrient system for individualized responsive dosing regimens
First Claim
Patent Images
1. A dietary supplement composition comprising at least two of the following in an amount equivalent to 5 drops in a liquid:
- about 2.77×
10−
7 g magnesium;
about 4.16×
10−
7 g sodium;
about 1.09×
10−
6 g potassium;
about 2.93×
10−
7 g calcium;
about 2.31×
10−
6 g asorbic acid;
about 2.19×
10−
7 g caffeine;
about 4.62×
10−
8 g niacin;
about 1.73×
10−
9 g chromium;
about 1.44×
10−
7 g coenzyme Q-10;
about 1.16×
10−
6 g L-glutamineabout 4.76×
10−
8 g vitamin A;
about 8.33×
10−
10 g vitamin B1;
about 6.29×
10−
10 g vitamin B2;
about 8.02×
10−
9 g vitamin B3;
about 8.02×
10−
9 g vitamin B6;
about 2.41×
10−
12 g vitamin B12;
about 2.41×
10−
8 g vitamin C;
about 3.81×
10−
9 g vitamin D3;
about 2.78×
10−
10 g vitamin E;
about 7.22×
10−
11 g vitamin H;
about 7.7×
10−
11 g folic acid;
about 3.53×
10−
10 g copper;
about 3.06×
10−
9 g iron;
orabout 2.58×
10−
9 g zinc,in one dose of the dietary supplement compositionwherein the dietary supplement composition is configured in an oral strip, sublingual liquid or spray that substantially avoids first pass metabolism.
2 Assignments
0 Petitions
Accused Products
Abstract
Individualized responsive dosing dietary supplement systems, compositions, methods of dosing, and processes of producing the same, which allow a consumer to generate individualistic biological responses/effects. More specifically, a dietary supplement system for generating individualized biological conditions/responses which utilizes ultra-low dosage amounts of vitamins, minerals, amino acids, co-enzymes, and/or other nutrients in a bio-active delivery system which preferably avoids first pass metabolism, such that an individual may take multiple doses of the same or different dietary supplement based on varying desired biological response within each 24 hour period is also disclosed.
26 Citations
1 Claim
-
1. A dietary supplement composition comprising at least two of the following in an amount equivalent to 5 drops in a liquid:
-
about 2.77×
10−
7 g magnesium;about 4.16×
10−
7 g sodium;about 1.09×
10−
6 g potassium;about 2.93×
10−
7 g calcium;about 2.31×
10−
6 g asorbic acid;about 2.19×
10−
7 g caffeine;about 4.62×
10−
8 g niacin;about 1.73×
10−
9 g chromium;about 1.44×
10−
7 g coenzyme Q-10;about 1.16×
10−
6 g L-glutamineabout 4.76×
10−
8 g vitamin A;about 8.33×
10−
10 g vitamin B1;about 6.29×
10−
10 g vitamin B2;about 8.02×
10−
9 g vitamin B3;about 8.02×
10−
9 g vitamin B6;about 2.41×
10−
12 g vitamin B12;about 2.41×
10−
8 g vitamin C;about 3.81×
10−
9 g vitamin D3;about 2.78×
10−
10 g vitamin E;about 7.22×
10−
11 g vitamin H;about 7.7×
10−
11 g folic acid;about 3.53×
10−
10 g copper;about 3.06×
10−
9 g iron;
orabout 2.58×
10−
9 g zinc,in one dose of the dietary supplement composition wherein the dietary supplement composition is configured in an oral strip, sublingual liquid or spray that substantially avoids first pass metabolism.
-
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeFoundational Biosystems LLC
-
Original AssigneeMicro Nutrient LLC
-
InventorsMoneymaker, Ricky Dean, Theus, Jon Scott, Klesman, Larry Scott
-
Primary Examiner(s)Wax; Robert A
-
Assistant Examiner(s)Barham; Bethany
-
Application NumberUS11/483,208Publication NumberTime in Patent Office1,425 DaysField of SearchNoneUS Class Current424/435CPC Class CodesA23L 33/15 VitaminsA23L 33/16 Inorganic salts, minerals o...A23L 33/175 Amino acidsA23L 33/30 Dietetic or nutritional met...A61K 2300/00 Mixtures or combinations of...A61K 31/00 Medicinal preparations cont...A61K 31/07 Retinol compounds, e.g. vit...A61K 31/355 Tocopherols, e.g. vitamin EA61K 31/375 Ascorbic acid, i.e. vitamin...A61K 31/4415 Pyridoxine, i.e. Vitamin B6...A61K 31/51 Thiamines, e.g. vitamin B1A61K 31/519 ortho- or peri-condensed wi...A61K 31/525 Isoalloxazines, e.g. ribofl...A61K 31/593 9,10-Secocholestane derivat...A61K 31/714 Cobalamins, e.g. cyanocobal...A61K 33/00 Medicinal preparations cont...A61K 33/24 Heavy metals; Compounds the...A61K 33/26 Iron; Compounds thereofA61K 33/30 Zinc; Compounds thereofA61K 33/34 Copper; Compounds thereofView All
